Accuracy of the serum intestinal fatty-acid-binding protein for diagnosis of acute intestinal ischemia: a meta-analysis
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Numerous studies have investigated the utility of serum intestinal fatty-acid binding protein (I-FABP) in differentiating acute intestinal ischemia from acute abdomen. However, the results remain controversial. The aim of this meta-analysis is to determine the overall accuracy of serum I-FABP in the diagnosis of acute intestinal ischemia. Publications addressing the accuracy of serum I-FABP in the diagnosis of ischemic bowel diseases were selected from databases. The values of true-positive (TP), true-negative (TN), false-positive (FP) and false-negative (FN) were extracted or calculated for each study. Pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR) and diagnostic odds ratio (DOR) were calculated. The overall diagnostic performance was assessed using a summary receiver operating characteristic curve (SROC) and area under curve (AUC). Nine studies that collectively included 1246 patients met the eligible criteria. The pooled sensitivity, specificity, DOR, PLR and NLR were 0.80 (95% CI: 0.72–0.86), 0.85 (95% CI: 0.73–0.93), 24 (95% CI: 9–65), 5.5 (95% CI: 2.8–10.8) and 0.23 (95% CI: 0.15–0.35), respectively. The AUC was 0.86 (95% CI: 0.83–0.89). The meta-analysis carried out in this report suggests that the I-FABP may be a useful diagnostic tool to confirm acute intestinal ischemia in acute abdomen, but better-designed trials are still required to confirm our findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whiting, P., Rutjes, A. W., Reitsma, J. B., Bossuyt, P. M., & Kleijnen, J. (2003) · BMC Medical Research Methodology · doi:10.1186/1471-2288-3-25 · Cited by 3,592
Deeks, J. J., Macaskill, P., & Irwig, L. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.01.016 · Cited by 2,910 · cited 1×
“Bias in publication was tested by using Deeks’ funnel plots 25 .”
Epidemiology of Mesenteric Vascular Disease: Clinical Implications
Acosta, S. (2010) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2009.12.001 · Cited by 340
Menke, J. (2010) · Radiology · doi:10.1148/radiol.10091938 · Cited by 319
Evennett, N. J., Petrov, M. S., Mittal, A., & Windsor, J. A. (2009) · World Journal of Surgery · doi:10.1007/s00268-009-0074-7 · Cited by 270
Early Diagnosis of Intestinal Ischemia Using Urinary and Plasma Fatty Acid Binding Proteins
Thuijls, G., Wijck, K. V., Grootjans, J., Derikx, J. P. M., van Bijnen, A. A., Heineman, E., Dejong, C. H. C., Buurman, W. A., & Poeze, M. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e318207a767 · Cited by 217 · cited 1×
“Overall, among 9 such studies of which only 1 study was carried out in USA 16 , 2 studies were from Netherlands 13,19 and the other 6 studies were all performed in Asia 10–12, 14 ,15,17 .”
Diagnostic accuracy of plasma biomarkers for intestinal ischaemia
Block, T., Nilsson, T. K., Björck, M., & Acosta, S. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510701646264 · Cited by 172 · cited 1×
“As a more feasible and less invasive alternative, I-FABP has attracted more and more attention of researchers 9–20 , 26– 37 .”
Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia
Matsumoto, S., Sekine, K., Funaoka, H., Yamazaki, M., Shimizu, M., Hayashida, K., & Kitano, M. (2014) · British Journal of Surgery · doi:10.1002/bjs.9331 · Cited by 135
Mensink, P. B. F., Hol, L., Borghuis-Koertshuis, N., Geelkerken, R. H., Huisman, A. B., Doelman, C. J. A., van Vuuren, A. J., Kuipers, E. J., & Kolkman, J. J. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832183a7 · Cited by 22
Research works printed but not linked: 30
- Furukawa, A. et al. CT diagnosis of acute mesenteric ischemia from various causes. AJR Am J Roentgenol 192, 408–416 (2009). · DOI · Paper page
- Angelelli, G. et al. Acute bowel ischemia: CT findings. Eur J Radiol 50, 37–47 (2004). · DOI
- Kozuch, P. L. et al. Review article: diagnosis and management of mesenteric ischemia with an emphasis on pharmacotherapy. Aliment Pharmacol Ther 21, 201–215 (2005). · DOI · Paper page
- Crenn, P. et al. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr 27, 328–339 (2008). · DOI · Paper page
- Cakmaz, R. et al. A combination of plasma DAO and citrulline levels as a potential marker for acute mesenteric ischemia. Libyan J Med 8, 1–6 (2013). · DOI
- Pelsers, M. M. et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem 36, 529–535 (2003). · DOI · Paper page
- Shi, H. et al. The role of serum intestinal fatty acid binding protein levels and D-lactate levels in the diagnosis of acute intestinal ischemia. Clin Res Hepatol Gastroenterol 39, 373–378 (2015). · DOI
- Kanda, T. et al. Diagnosis of ischemic small bowel disease by measurement of serum intestinal fatty acid-binding protein in patients with acute abdomen: a multicenter, observer-blinded validation study. J Gastroenterol 46, 492–500 (2011). · DOI
- Kittaka, H. et al. Usefulness of intestinal fatty acid-binding protein in predicting strangulated small bowel obstruction. PLoS One 13, e99915 (2014). · DOI · Paper page
- Jin, H. Value of intestinal fatty acid binding protein in diagnose of ischemic bowel disease. Chin J Immuno (Chinese) 30, 531–533 (2014).
- Cronk, D. R. et al. Intestinal fatty acid binding protein (I-FABP) for the detection of strangulated mechanical small bowel obstruction. Curr Surg 63, 322–325 (2006). · DOI
- Shi, H. et al. The value of serum intestinal fatty acid blinding protein measurement in discriminating intestinal ischemia in patients with acute abdomen. Chin J Intern Med (Chinese) 51, 690–693 (2012).
- Vermeulen Windsant, I. C. et al. Circulating intestinal fatty acid-binding protein as an early marker of intestinal necrosis after aortic surgery: a prospective observational cohort study. Ann Surg 255, 796–803 (2012). · DOI · Paper page
- van der Voort, P. H. et al. Can serum L-lactate, D-lactate, creatine kinase and I-FABP be used as diagnostic markers in critically ill patients suspected for bowel ischemia. BMC Anesthesiol 14, 111 (2014). · DOI · Paper page
- Leeflang, M. M. et al. Systematic reviews of diagnostic test accuracy. Ann Intern Med 149, 889–897 (2008). · DOI · Paper page
- Jones, C. M. et al. Diagnostic accuracy meta-analysis: a review of the basic principles of interpretation and application. Int J Cardiol 140, 138–144 (2010). · DOI
- Higgins, J. P. et al. Measuring inconsistency in meta-analyses. BMJ 327, 557–560 (2003). · DOI · Paper page
- Kanda, T. et al. Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 110, 339–343 (1996). · DOI · Paper page
- Hu, K. Q. et al. Change of plasma intestinal fatty acid-binding protein and liver fatty acid-binding protein in children with intestinal ischemia. J Clin Pedia Surg (Chinese) 9, 95–97 (2010).
- Hu, K. Q. et al. The value of serum intestinal fatty acid blinding protein measurement in discriminating intestinal ischemia in children. Shanxi Med J (Chinese) 39, 418–419 (2010).
- Yan, W. L. et al. Diagnostic value of plasma intestinal fatty acid-binding protein and creatine kinase in patients subjected with intestinal obstruction. Zhongguo Zhong Xi Yi Jie He Za Zhi (Chinese) 19, 624–626 (2013).
- Li, L. & Liang, H. F. Application of IFABP, LFABP detection technology in children with intestinal ischemia. Chin J Pharma Econom (Chinese) 1, 64–66 (2012).
- Jin, H. The relationship between intestinal fatty acid binding protein and the severity and prognosis of ischemic bowel disease. Zhe Jiang Lin Chuang Yi Xue (Chinese) 16, 371–372 (2014).
- Shen, D. H. et al. The value of serum intestinal fatty acid blinding protein in intestinal diseases. Shi Yong Yi Xue Za Zhi (Chinese) 21, 2535–2536 (2005).
- van Noord, D. et al. Serum markers and intestinal mucosal injury in chronic gastrointestinal ischemia. Dig Dis Sci 56, 506–512 (2011). · DOI
- Wang, H. et al. The diagnosis value of combination of I-FABP, D-LAC, Fg in acute ischemic enteritis. Lin Chuang He Li Yong Yao (Chinese) 7, 144–145 (2014).
- Zheng, L. et al. The value of I-FABP measurement in the diagnosis of intestinal ischemic in patients with acute intestinal obstruction. Int J Lab Med (Chinese) 35, 410–411 (2014).
- Wang, H. et al. The diagnosing value of I-FABP, D-LAC in ischemic enteritis. Lin Chuang He Li Yong Yao (Chinese) 7, 112–114 (2014).
- Riffelmann, M. et al. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. J Clin Microbiol 48, 4459–4463 (2010). · doi:10.1128/jcm.01371-10
- van de Wouw, B. A. et al. Comparison of three commercially available enzyme-linked immunosorbent assays and biopsy-dependentdiagnosis for detecting Helicobacter pylori infection. J Clin Microbiol 34(1), 94–97 (1996). · doi:10.1128/jcm.34.1.94-97.1996
Cited by
Biochemical markers of acute intestinal ischemia: Possibilities and limitations
Montagnana, M., Danese, E., & Lippi, G. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.07.22 · Cited by 108
Serological markers for human intestinal ischemia: A systematic review
Derikx, J. P. M., Schellekens, D. H. S. M., & Acosta, S. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.01.004 · Cited by 96
Diagnosis biomarkers in acute intestinal ischemic injury: so close, yet so far
Peoc’h, K., Nuzzo, A., Guedj, K., Paugam, C., & Corcos, O. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0291 · Cited by 86
Reintam Blaser, A., Starkopf, J., Björck, M., Forbes, A., Kase, K., Kiisk, E., Laisaar, K.-T., Mihnovits, V., Murruste, M., Mändul, M., et al. (2023) · World Journal of Emergency Surgery · doi:10.1186/s13017-023-00512-9 · Cited by 67
Accuracy of citrulline, I-FABP and d-lactate in the diagnosis of acute mesenteric ischemia
Nuzzo, A., Guedj, K., Curac, S., Hercend, C., Bendavid, C., Gault, N., Tran-Dinh, A., Ronot, M., Nicoletti, A., Bouhnik, Y., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-98012-w · Cited by 67
Rittgerodt, N., Pape, T., Busch, M., Becker, L. S., Schneider, A., Wedemeyer, H., Seeliger, B., Schmidt, J., Hunkemöller, A. M., Fuge, J., et al. (2022) · Critical Care · doi:10.1186/s13054-022-03962-w · Cited by 26
“i-FABP has been explored as a more speci c indicator of mucosal intestinal injury (25) in acute mesenteric ischemia in general (26, 27) as well as in NOMI (28) and was found to have a high positive predictive value for diagnosis of NOMI when compared to routine clinical biomarkers (28).”
BackgroundMonroy, D. M. C., Arango, F. G., Moreno, L. R., Chaves, C. E. R., Donoso-Samper, A., Nassar, R., & Isaza-Restrepo, A. (2022) · Annals of Medicine & Surgery · doi:10.1016/j.amsu.2022.104922 · Cited by 8
Metadata
- Authors
- Sun, D.-L., Cen, Y.-Y., Li, S.-M., Li, W.-M., Lu, Q.-P., & Xu, P.-Y.
- Venue
- Scientific Reports
- Published
- 2016-09-29
- Volume
- 6
- Issue
- 1
- Pages
- 34371-34371
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2525164642
- Cited by
- 88
- References
- 9
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.